Related Experiment Video
Updated: Jan 15, 2026

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
Coagulation Dysfunction and Prognosis in Severe Fever With Thrombocytopenia Syndrome: A Comprehensive Analysis
Bo Zhang1, Chaojun Duan1, Jiale Gong1
1Department of Laboratory Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
None:
Severe Fever with Thrombocytopenia Syndrome (SFTS) is a zoonotic infectious disease with high mortality, in which coagulation dysfunction triggered by the virus serves as a critical factor in disease progression and patient death. This study comprehensively analyzed coagulation characteristics and the impact of concomitant Disseminated Intravascular Coagulation (DIC) on prognosis in 187 SFTS patients. Significant differences (p < 0.05) in coagulation parameters were observed among SFTS patients with varying disease severity and viral loads. The dynamic changes in coagulation parameters, especially activated partial thromboplastin time(APTT) and d-dimer (DD), differed significantly between the survival group and the death group. Prothrombin time(PT), International Normalized Ratio(INR), APTT, thrombin time(TT), and DD were identified as independent risk factors for death in SFTS patients. Furthermore, APTT ≥ 51.3 s (p = 0.001), TT ≥ 30.5 s (p = 0.023), and DD ≥ 2.39 µg/mL (p = 0.009) were shown to be effective predictors of patient mortality. Additionally, significant differences (p < 0.001) in admission coagulation parameters were found in SFTS patients complicated by DIC, among whom APTT was identified as an independent risk factor for death in this subgroup. Therefore, monitoring coagulation parameters aids in the early identification of high-risk patients, and intensive coagulation management may help improve patient prognosis.
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Coagulation
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...

